Clinical Trial Update: A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) [Phase 3]

View source ↗

Summary

This is a completed Phase 3 study evaluating Vedolizumab in children and teenagers with moderate to severe ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Entyvio (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Colitis, Ulcerative | Phase 3 | Status: COMPLETED